Lung Stereotactic Body Radiotherapy for Early-Stage NSCLC in Patients With Prior Pneumonectomy: A Case Report
Stereotactic body radiotherapy (SBRT) has become the standard of care for patients with medically inoperable early-stage non-small cell lung cancer. A paucity of published data exists regarding the safety of SBRT use in patients with prior pneumonectomy. This report describes 2 patients with non-small cell lung cancer and prior pneumonectomy who were treated with lung SBRT with a favorable treatment response and no major adverse treatment effects. The data presented herein are promising and provide early evidence that lung SBRT is a safe and feasible option in this subset of patients.
Target Audience
This activity has been designated to meet the educational needs of physicians and nurses involved in the management of patients with cancer.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Explain the benefits of stereotactic body radiotherapy (SBRT) for patients with a prior pneumonectomy
Daniel R. Simpson, MD
Center for Advanced Radiotherapy Technologies
Department of Radiation Medicine and Applied Sciences
University of California San Diego
La Jolla, California
Parag Sanghvi, MD, MSPH
Center for Advanced Radiotherapy Technologies
Department of Radiation Medicine and Applied Sciences
University of California San Diego
La Jolla, California
Ajay P. Sandhu, MD
Center for Advanced Radiotherapy Technologies
Department of Radiation Medicine and Applied Sciences
University of California San Diego
La Jolla, California
Available Credit
- 0.50 Participation
- 0.50 Nurse
- 0.50 Physician
Price
Required Hardware/software
To access this activity, users will need:
- A device with an Internet connection
- Adobe Reader or other PDF reader software for article and certificate viewing/printing